Osaic Holdings’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$117 Sell
15
-5
-25% -$52 ﹤0.01% 7615
2025
Q4
$236 Hold
20
﹤0.01% 7562
2025
Q3
$141 Sell
20
-80
-80% -$557 ﹤0.01% 7727
2025
Q2
$801 Hold
100
﹤0.01% 7224
2025
Q1
$706 Buy
100
+11
+12% +$119 ﹤0.01% 6912
2024
Q4
$1.01K Hold
89
﹤0.01% 6846
2024
Q3
$1.24K Buy
+89
New +$1.42K ﹤0.01% 6774
2024
Q2
Sell
-11
Closed -$293 7562
2024
Q1
$293 Hold
11
﹤0.01% 6906
2023
Q4
$219 Sell
11
-3
-21% -$41 ﹤0.01% 7030
2023
Q3
$182 Buy
14
+3
+27% +$49 ﹤0.01% 7168
2023
Q2
$204 Sell
11
-69
-86% -$1.36K ﹤0.01% 7204
2023
Q1
$1.54K Buy
80
+49
+158% +$1.33K ﹤0.01% 6817
2022
Q4
$1K Buy
31
+27
+675% +$681 ﹤0.01% 6922
2022
Q3
$0 Sell
4
-5
-56% -$197 ﹤0.01% 7442
2022
Q2
$0 Sell
9
-7
-44% -$327 ﹤0.01% 7530
2022
Q1
$1K Buy
16
+1
+7% +$82 ﹤0.01% 7094
2021
Q4
$2K Buy
15
+2
+15% +$327 ﹤0.01% 7040
2021
Q3
$2K Buy
13
+1
+8% +$238 ﹤0.01% 6879
2021
Q2
$3K Hold
12
﹤0.01% 6618
2021
Q1
$4K Buy
+12
New +$5.12K ﹤0.01% 6280

Other funds holding PASG

Osaic Holdings's PASG Position: Q1 2026 in Review

Osaic Holdings reduced its Passage Bio (PASG) stake by 25% in Q1 2026, selling an estimated $52 and leaving 15 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #7615.

Osaic Holdings first reported a position in PASG in Q1 2021 and has held it in 20 quarters since. The position peaked at $4K in Q1 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Osaic Holdings held 15 shares of Passage Bio worth $117 as of Q1 2026.
  • Osaic Holdings sold 5 Passage Bio shares in Q1 2026, an estimated $52.
  • Passage Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7615 holding.
  • Osaic Holdings first reported a position in Passage Bio in Q1 2021 and has held it in 20 quarters since.
  • Osaic Holdings's Passage Bio position peaked at $4K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.